148 related articles for article (PubMed ID: 37856381)
1. Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
Picart T; Pallud J; Berthiller J; Dumot C; Berhouma M; Ducray F; Armoiry X; Margier J; Guerre P; Varlet P; Meyronet D; Metellus P; Guyotat J;
J Neurosurg; 2024 Apr; 140(4):987-1000. PubMed ID: 37856381
[TBL] [Abstract][Full Text] [Related]
2. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
3. Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid.
Herta J; Cho A; Roetzer-Pejrimovsky T; Höftberger R; Marik W; Kronreif G; Peilnsteiner T; Rössler K; Wolfsberger S
J Neurosurg; 2023 Aug; 139(2):334-343. PubMed ID: 36681953
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-ALA dose on resection of glioblastoma.
Michael AP; Watson VL; Ryan D; Delfino KR; Bekker SV; Cozzens JW
J Neurooncol; 2019 Feb; 141(3):523-531. PubMed ID: 30644009
[TBL] [Abstract][Full Text] [Related]
5. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
6. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
7. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE; Kennedy J; Moulding HD; Zucker L; Chicoine MR; Olson JJ; Jensen RL; Sherman JH; Zhang X; Price G; Fowkes M; Germano IM; Carter BS; Hadjipanayis CG; Yong RL
J Neurosurg; 2022 Jun; 136(6):1525-1534. PubMed ID: 34624862
[TBL] [Abstract][Full Text] [Related]
9. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
Roder C; Stummer W; Coburger J; Scherer M; Haas P; von der Brelie C; Kamp MA; Löhr M; Hamisch CA; Skardelly M; Scholz T; Schipmann S; Rathert J; Brand CM; Pala A; Ernemann U; Stockhammer F; Gerlach R; Kremer P; Goldbrunner R; Ernestus RI; Sabel M; Rohde V; Tabatabai G; Martus P; Bisdas S; Ganslandt O; Unterberg A; Wirtz CR; Tatagiba M
J Clin Oncol; 2023 Dec; 41(36):5512-5523. PubMed ID: 37335962
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinic Acid-Shedding Light on Where to Focus.
Dadario NB; Khatri D; Reichman N; Nwagwu CD; D'Amico RS
World Neurosurg; 2021 Jun; 150():9-16. PubMed ID: 33684574
[TBL] [Abstract][Full Text] [Related]
12. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid-Guided Surgery: A Systematic Review and Meta-Analysis.
Gandhi S; Tayebi Meybodi A; Belykh E; Cavallo C; Zhao X; Syed MP; Borba Moreira L; Lawton MT; Nakaji P; Preul MC
Front Oncol; 2019; 9():620. PubMed ID: 31380272
[No Abstract] [Full Text] [Related]
13. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.
Schucht P; Seidel K; Beck J; Murek M; Jilch A; Wiest R; Fung C; Raabe A
Neurosurg Focus; 2014 Dec; 37(6):E16. PubMed ID: 25434385
[TBL] [Abstract][Full Text] [Related]
14. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
[TBL] [Abstract][Full Text] [Related]
15. Fluorescein-guided surgery in high-grade gliomas: focusing on the eloquent and deep-seated areas.
Xiao Y; Li M; Wang X; Tan J; Qin C; Liu Q
J Cancer Res Clin Oncol; 2024 May; 150(5):274. PubMed ID: 38795238
[TBL] [Abstract][Full Text] [Related]
16. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
18. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative imaging technology to maximise extent of resection for glioma: a network meta-analysis.
Fountain DM; Bryant A; Barone DG; Waqar M; Hart MG; Bulbeck H; Kernohan A; Watts C; Jenkinson MD
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013630. PubMed ID: 33428222
[TBL] [Abstract][Full Text] [Related]
20. Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial.
Vermandel M; Dupont C; Lecomte F; Leroy HA; Tuleasca C; Mordon S; Hadjipanayis CG; Reyns N
J Neurooncol; 2021 May; 152(3):501-514. PubMed ID: 33743128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
